Xetrios Therapeutics Inc entered the industry of Commercial Biotechnical Research in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Benedikt Vollrath by calling (858) 999-4413 during business hours. You can also write to the business’ Single Location at 4704 Niagara Avenue, San Diego, California CA 92107. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Xetrios Therapeutics Inc |
Representative: | Benedikt Vollrath |
Place of Business: | 4704 Niagara Avenue, San Diego, CA 92107 |
Contact Number: | (858) 999-4413 |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 541711 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2009 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Xetrios Therapeutics Inc is a company operating from San Diego, California providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2009 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Xetrios Therapeutics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Benedikt Vollrath at (858) 999-4413 for related queries, or to locate its Single Location using the coordinates 32.743012,-117.246633.
The Single Location can also be found at the street address 4704 Niagara Avenue in San Diego, California 92107 and can be engaged online through the company website at , the company Twitter , and Facebook page .